EdgarLookup

Compass Therapeutics, Inc. — 10-Q Filings

23 10-Q filings on record

This page lists all 10-Q filings submitted to the SEC by Compass Therapeutics, Inc. (CMPX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Compass Therapeutics, Inc. has filed 23 10-Q documents with the SEC since 2018. To view all SEC filings by Compass Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-12G 10-K 10-Q 144 3 4 4/A 424B3 424B5 8-A12B 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DEL AM DRS EFFECT POS AM RW S-1 S-1/A S-3 S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC 14F1 SC 14F1/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
10-Q FORM 10-Q 0001171843-25-007005 Nov 5, 2025 Sep 30, 2025
10-Q FORM 10-Q 0001171843-25-005261 Aug 11, 2025 Jun 30, 2025
10-Q FORM 10-Q 0001171843-25-002953 May 8, 2025 Mar 31, 2025
10-Q FORM 10-Q 0001171843-24-006248 Nov 12, 2024 Sep 30, 2024
10-Q FORM 10-Q 0001171843-24-004670 Aug 12, 2024 Jun 30, 2024
10-Q FORM 10-Q 0001171843-24-002785 May 13, 2024 Mar 31, 2024
10-Q FORM 10-Q 0001171843-23-006912 Nov 9, 2023 Sep 30, 2023
10-Q FORM 10-Q 0001171843-23-004947 Aug 3, 2023 Jun 30, 2023
10-Q FORM 10-Q 0001171843-23-002868 May 4, 2023 Mar 31, 2023
10-Q FORM 10-Q 0001171843-22-007269 Nov 9, 2022 Sep 30, 2022
10-Q FORM 10-Q 0001171843-22-005187 Aug 1, 2022 Jun 30, 2022
10-Q 10-Q 0000950170-22-008244 May 9, 2022 Mar 31, 2022
10-Q 10-Q 0000950170-21-004267 Nov 12, 2021 Sep 30, 2021
10-Q 10-Q 0000950170-21-001486 Aug 16, 2021 Jun 30, 2021
10-Q 10-Q 0001564590-21-022412 Apr 30, 2021 Mar 31, 2021
10-Q 10-Q 0001564590-20-052190 Nov 9, 2020 Sep 30, 2020
10-Q 10-Q 0001564590-20-039951 Aug 13, 2020 Jun 30, 2020
10-Q QUARTERLY REPORT 0001213900-20-003689 Feb 14, 2020 Dec 31, 2019
10-Q QUARTERLY REPORT 0001213900-19-023231 Nov 13, 2019 Sep 30, 2019
10-Q QUARTERLY REPORT 0001213900-19-015578 Aug 13, 2019 Jun 30, 2019
10-Q QUARTERLY REPORT 0001213900-19-002496 Feb 14, 2019 Dec 31, 2018
10-Q QUARTERLY REPORT 0001213900-18-015798 Nov 14, 2018 Sep 30, 2018
10-Q QUARTERLY REPORT 0001213900-18-010934 Aug 14, 2018 Jun 30, 2018